HMGA2 Stabilizes hnRNPK to Drive YAP-Dependent Liver Metastasis in Pancreatic Cancer
International Journal of Biological Sciences · 2026
DOI: 10.7150/ijbs.133139 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2026. Verfasst von Yu Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic and Metabolic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Chin…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Liver Neoplasms, HMGA2 Protein, Transcription Factors. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Pancreatic cancer (PC) is a highly aggressive malignant neoplasm with a propensity for liver metastasis (LM), which significantly contributes to poor patient prognosis, but its molecular mechanism remains incompletely elucidated. In this study, we demonstrated that high mobility group protein A2 (HMGA2) is markedly elevated in LM tissues and circulating tumor cells (CTCs) of PC patients. Mechanistically, HMGA2 binds to heterogeneous nuclear ribonucleoprotein K (hnRNPK) via "AT-hook" functional motif, suppressing its ubiquitination to block proteasomal degradation. This interaction promotes the transcriptional activation of Yes-associated protein (YAP) by facilitating hnRNPK binding to the YAP promoter and thereby enhancing metastatic potential of PC. Functional assays validate that hnRNPK mediates HMGA2's pro-metastatic function, and YAP acts as the indispensable downstream effector of this cascade. Our findings establish the HMGA2/hnRNPK-YAP axis as a critical regulator of LM and propose targeting this pathway as a promising therapeutic strategy for metastatic PC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pancreatic and Metabolic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Key Laboratory of Molecular Medicine, Chemistry and Biomedicine Innovation Center, Medical School of Nanjing University, Nanjing, China.
Zitieren
APA
Xie, Y., Hang, H., Liu, H., Wang, N., Wang, C., Yang, Y., Fang, L., Qiu, Y., & Cheng, H. (2026). HMGA2 Stabilizes hnRNPK to Drive YAP-Dependent Liver Metastasis in Pancreatic Cancer. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.133139
Vancouver
Xie Y, Hang H, Liu H, Wang N, Wang C, Yang Y, et al. HMGA2 Stabilizes hnRNPK to Drive YAP-Dependent Liver Metastasis in Pancreatic Cancer. International Journal of Biological Sciences. 2026. doi:10.7150/ijbs.133139
BibTeX
@article{Xie2026,
author = {Xie, Yu and Hang, Hexing and Liu, Haobai and Wang, Nannan and Wang, Chengzhi and Yang, Yifei and Fang, Lei and Qiu, Yudong and Cheng, Hao},
title = {HMGA2 Stabilizes hnRNPK to Drive YAP-Dependent Liver Metastasis in Pancreatic Cancer},
journal = {International Journal of Biological Sciences},
year = {2026},
doi = {10.7150/ijbs.133139}
}
EUVIMED